Goldman Sachs Group Inc Amgen Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 5,005,143 shares of AMGN stock, worth $1.44 Billion. This represents 0.27% of its overall portfolio holdings.

Number of Shares

5,005,143

Previous 5,181,630 3.41%

Holding current value

$1.44 Billion

Previous $1.62 Billion 0.39%

% of portfolio

0.27%

Previous 0.28%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $54.6 Million - $59.5 Million	-176,487 Reduced 3.41%	5,005,143 $1.61 Billion
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $230 Million - $280 Million	876,921 Added 20.37%	5,181,630 $1.62 Billion
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $121 Million - $147 Million	451,809 Added 11.73%	4,304,709 $1.22 Billion
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $73.2 Million - $82.6 Million	286,452 Added 8.03%	3,852,900 $1.11 Billion
Q3 2023 May 14, 2024	SELL	$218.65 - $271.46 $62.6 Million - $77.8 Million	-286,452 Reduced 7.43%	3,566,448 $959 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $148 Million - $183 Million	675,328 Added 23.36%	3,566,448 $959 Million
Q2 2023 May 14, 2024	BUY	$214.27 - $253.37 $42.1 Million - $49.7 Million	196,332 Added 7.29%	2,891,120 $642 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $42.1 Million - $49.7 Million	196,332 Added 7.29%	2,891,120 $642 Million
Q1 2023 May 14, 2024	BUY	$225.79 - $275.2 $5.38 Million - $6.56 Million	23,835 Added 0.89%	2,694,788 $651 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $5.38 Million - $6.56 Million	23,835 Added 0.89%	2,694,788 $651 Million
Q4 2022 May 14, 2024	SELL	$229.03 - $291.01 $1.44 Billion - $1.82 Billion	-6,266,036 Reduced 70.11%	2,670,953 $701 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.44 Billion - $1.82 Billion	-6,266,036 Reduced 70.11%	2,670,953 $701 Million
Q3 2022 May 14, 2024	BUY	$224.46 - $253.15 $429 Million - $484 Million	1,912,446 Added 27.23%	8,936,989 $2.01 Billion
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $429 Million - $484 Million	1,912,446 Added 27.23%	8,936,989 $2.01 Billion
Q2 2022 May 14, 2024	BUY	$230.71 - $256.74 $732 Million - $814 Million	3,171,643 Added 82.32%	7,024,543 $1.71 Billion
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.03 Billion - $1.15 Billion	4,462,166 Added 174.14%	7,024,543 $1.71 Billion
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $227 Million - $251 Million	-1,035,106 Reduced 28.77%	2,562,377 $620 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $102 Million - $116 Million	510,832 Added 16.55%	3,597,483 $809 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $655 Million - $768 Million	3,086,651 New	3,086,651 $656 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Amgen Inc Transaction History